Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Levy

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitisChristopher L Bowlus, Cynthia Levy
Current Treatment Options in Gastroenterology|October 31, 2003
Management of Primary Biliary CirrhosisCynthia Levy, Keith D. Lindor
Inflammatory Bowel Diseases|February 21, 2002
Management of internal fistulas in Crohn's diseaseCynthia Levy, William J Tremaine
Clinics in Liver Disease|November 5, 2003
Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosisCynthia Levy, Keith D Lindor
The American Journal of Gastroenterology|January 10, 2018
Editorial: Itching to Know: Role of Fibrates in PBCCynthia Levy, Keith D Lindor
Nature Clinical Practice. Gastroenterology & Hepatology|February 10, 2007
What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?Virginia C Clark, Cynthia Levy
The American Journal of Gastroenterology|July 24, 2020
Role of Antinuclear Antibodies in Primary Biliary CholangitisCynthia Levy, Christopher L Bowlus
Current Treatment Options in Gastroenterology|March 12, 2003
Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing CholangitisCynthia Levy, Keith D. Lindor
Hepatology (Baltimore, Md.)|January 6, 2021
Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled TrialsDavid N Assis, Cynthia Levy
Seminars in Liver Disease|February 24, 2006
Primary sclerosing cholangitis: epidemiology, natural history, and prognosisCynthia Levy, Keith D Lindor
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitisChristopher L Bowlus, Cynthia Levy
Current Treatment Options in Gastroenterology|October 31, 2003
Management of Primary Biliary CirrhosisCynthia Levy, Keith D. Lindor
Inflammatory Bowel Diseases|February 21, 2002
Management of internal fistulas in Crohn's diseaseCynthia Levy, William J Tremaine
Clinics in Liver Disease|November 5, 2003
Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosisCynthia Levy, Keith D Lindor
The American Journal of Gastroenterology|January 10, 2018
Editorial: Itching to Know: Role of Fibrates in PBCCynthia Levy, Keith D Lindor
Nature Clinical Practice. Gastroenterology & Hepatology|February 10, 2007
What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?Virginia C Clark, Cynthia Levy
The American Journal of Gastroenterology|July 24, 2020
Role of Antinuclear Antibodies in Primary Biliary CholangitisCynthia Levy, Christopher L Bowlus
Current Treatment Options in Gastroenterology|March 12, 2003
Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing CholangitisCynthia Levy, Keith D. Lindor
Hepatology (Baltimore, Md.)|January 6, 2021
Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled TrialsDavid N Assis, Cynthia Levy
Seminars in Liver Disease|February 24, 2006
Primary sclerosing cholangitis: epidemiology, natural history, and prognosisCynthia Levy, Keith D Lindor
Pageof 21